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Abstract:  In  this  article  we  critically  review  the  economic  literature  on  the  effects  of 
environmental changes on public health, in both the developed and the developing world. 
We first focus on the economic methodologies that are available for the evaluation of the 
effects (social costs and benefits) of environmental changes (degradation/preservation) on 
public health. Then, we explain how the monetary valuations of these effects can feed back 
in  the  construction  of  economic  policy  for  creating  agent-specific  incentives  for  more 
efficient  public  health  management,  which  is  also  equitable  and  environmentally 
sustainable.  Our  exposition  is  accompanied  by  a  synthesis  of  the  available  quantitative 
empirical results. 
Keywords: health risks; environmental management; valuation 
 
Every minute, five children in developing countries die from malaria or diarrhoea. Every hour, 100 
children die as a result of exposure to indoor smoke from solid fuels. Every day, nearly 1,800 people in 
developing cities die as a result of exposure to urban air pollution. Every month, nearly 19,000 people 
in developing countries die from unintentional poisonings. 
Source: Health and Environment: Tools for Effective Decision-Making: 
the WHO/UNEP Health and Environment Linkages Initiative Review of 
Initial Findings, 2004. 
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1. Introduction 
 
The environment affects our health in a variety of ways. The interaction between human health and 
the  environment  has  been  extensively  studied  and  environmental  risks  have  been  proven  to 
significantly impact human health, either directly by exposing people to harmful agents, or indirectly, 
by disrupting life-sustaining ecosystems [1]. Although the exact contribution of environmental factors 
to  the  development  of  death  and  disease  cannot  be  precisely  determined,  the  World  Health 
Organization (WHO) has estimated that thirteen million deaths annually are attributable to preventable 
environmental causes [1]. The report also estimates that 24% of the global disease burden (healthy life 
years lost) and 23% of all deaths (premature mortality) are attributable to environmental factors, with 
the environmental burden of diseases being 15 times higher in developing countries than in developed 
countries, due to differences in exposure to environmental risks and access to health care. 
However, huge economic development and population growth result in continuing environmental 
degradation. Intensification of agriculture, industrialization and increasing energy use are the most 
severe  driving  forces  of  environmental  health  problems.  For  countries  in  the  early  stages  of 
development the major environmental hazards to health are associated with widespread poverty and 
severe lack of public infrastructure, such as access to drinking water, sanitation, and lack of health care 
as well as emerging problems of industrial pollution. However, environmental health hazards are not 
limited to the developing world. Although at a lesser extend, environmental risks are also present in 
wealthier  countries  and  are  primarily  attributed  to  urban  air  and  water  pollution.  Occurrences  of 
Asthma are rising dramatically throughout the developed countries, and environmental factors appear 
to be at least partly to blame [1]. The Millennium Ecosystem Assessment [2] synthesis report warns 
that the erosion of ecosystems could  lead to an  increase  in existing diseases  such as  malaria  and 
cholera, as well as a rising risk of new diseases emerging. 
Climate change is also posing risks to human population health and well-being and thus is emerging 
as a serious concern worldwide [3-6]. In 2000 climate change was estimated to be responsible for 
approximately 2.4% of worldwide diarrhoea and 6% of  malaria  [1]. According to the IPCC third 
assessment  report  the  world  temperature  is  expected  to  further  rise  during  the  century,  implying 
increased health threats for human populations, especially in low-income countries. Reviewing the US 
literature addressing  health  impacts of climate variability and change Ebi  et al. [7], conclude that 
climate change  is expected to increase  morbidity and  mortality risks  from climate-sensitive health 
outcomes such as extreme heat events, floods, droughts and fires. A spread in vector–borne diseases, 
like malaria, is also expected [8,9]. A study in Mexico revealed that lower greenhouse gases emissions 
would result in avoidance of some 64,000 premature deaths over a twenty year period [4]. Leading 
death causes worldwide (2004) are summarized in Table 1.  
 
Table 1. The 10 leading causes of death by broad income group (2004). 
Low-income countries  Deaths in millions  % of deaths 
Lower respiratory infections   2.94   11.2  
Coronary heart disease   2.47   9.4  
Diarrhoeal diseases   1.81   6.9  Int. J. Environ. Res. Public Health 2009, 6                 
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Table 1. Cont. 
HIV/AIDS   1.51   5.7  
Stroke and other cerebrovascular diseases   1.48   5.6  
Chronic obstructive pulmonary disease   0.94   3.6  
Tuberculosis   0.91   3.5  
Neonatal infections   0.90   3.4  
Malaria   0.86   3.3  
Prematurity and low birth weight   0.84   3.2  
High-income countries  Deaths in millions  % of deaths 
Coronary heart disease  1.33  16.3 
Stroke and other cerebrovascular diseases  0.76  9.3 
Trachea, bronchus, lung cancers  0.48  5.9 
Lower respiratory infections  0.31  3.8 
Chronic obstructive pulmonary disease  0.29  3.5 
Alzheimer and other dementias  0.28  3.4 
Colon and rectum cancers  0.27  3.3 
Diabetes mellitus  0.22  2.8 
Breast cancer  0.16  2.0 
Stomach cancer  0.14  1.8 
Source: World Health Organization [10]. 
 
This  paper  provides  a  review  of  the  literature  on  valuation  studies  eliciting  monetary  values 
associated with reduced environmental risk and in particular focusing on reduced indoor and outdoor 
air pollution, enhanced  water quality and climate change mitigation. The findings of the valuation 
studies have important policy implications, since the environmental risk factors that are studied can 
largely  be  avoided  by  efficient  and  sustainable  policy  interventions.  Minimizing  exposure  to 
environmental risk factors by enhancing air quality and access to improved sources of drinking and 
bathing water, sanitation and clean energy is found to be associated with significant health benefits and 
can  contribute  significantly  to  the  achievement  of  the  Millennium  Development  Goals  of 
environmental sustainability, health and development. 
 
2. Economic Valuation Techniques  
 
Quantifying  the  impacts  of  environmental  degradation  on  human  health  is  essential  for  the 
development of well-informed policies by the health sector and consequently many valuation studies 
have been conducted worldwide the past decades addressing environmental risks to public health. The 
main  approaches  for  health  impact  valuations  can  be  broadly  classified  into  revealed  and  stated 
preference  techniques.  The  first  take  into  account  observable  market  information  which  can  be 
adjusted and used for revealing an individual’s valuation. Revealed preferences include cost of illness, 
human  capital  surveys,  hedonic  pricing  and  the  Quality  Adjusted  Life  Year  studies.  In  stated Int. J. Environ. Res. Public Health 2009, 6                 
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preferences studies the market for the good is ‘constructed’ through the use of questionnaires. The two 
most-well-known stated preference  methods are the Contingent Valuation Method  (CVM) and the 
Choice Experiments (CE). 
Cost  of  illness  studies  measure  the  direct  (medical  costs,  nursing  care,  drugs)  and  indirect 
(opportunity) economic costs associated with a disease and estimate the potential savings from the 
eradication of the disease. Human capital surveys estimate the productivity loss measured in workdays 
due to illness. This approach also values loss of life based on the foregone earnings associated with 
premature mortality. The notion is that people should be willing to pay at least as much as the value of 
the income they would lose by dying prematurely. 
Damage costs estimates from environmental hazards for the economy as a whole are also obtained 
through  general  equilibrium  macroeconomic  modeling.  These  studies  assess  welfare  impacts  in  a 
national  or  international  level  by  examining  all  the  sectors  of  the  economy  and  estimating 
environmental health impacts on parameters of the economy like income and consumption. 
The Quality Adjusted Life Year (QALY) studies measure both the quality and quantity of life. The 
values for a Life Year range from 0, implying death, to 1, implying a year of perfect health. Therefore, 
QALYs provide an indication of the benefits from a healthcare intervention in terms of health-related 
quality. Combined with the costs of providing different interventions, a cost-effectiveness analysis 
(cost per QALY) can follow to allow for comparisons of different interventions. A monetary value can 
also be placed on a QALY to estimate the dollar benefits of a health intervention or policy and allow 
for  a  subsequent  cost-benefit  analysis.  Stated  Willingness  to  Pay,  elicited  through  a  contingent 
valuation study or a discrete choice study, is often used, to monetize QALYs. Other methods to value a 
QALY  include  time-trade-offs,  standard  gamble  and  the  visual  analogue  scale.  Hedonic  pricing 
methods assess differences in the price of housing in polluted or unpolluted areas, or the difference in 
wages between hazardous and non-hazardous jobs. Variations in housing prices and wages reflect the 
value of health damages avoided to those individuals and therefore reveal individual’s willingness to 
pay to avoid damages. 
Stated preference approaches include the Contingent Valuation Method and Choice Experiments. 
The respective differences between the two methodologies relate to the way in which the economic 
values are elicited. In a contingent valuation questionnaire respondents are presented with a valuation 
scenario that describes the changes in the provision of the public good resulting from the policy under 
evaluation and, in the simplest open-ended format, are asked about their maximum Willingness to Pay 
for the policy to be implemented. Grounded on Lancaster’s theory of value [11], choice experiments 
describe  the  good  under  evaluation  in  terms  of  its  characteristics,  attributes,  and  the  levels  these 
attributes take. One of the attributes is usually price, so that the marginal value of the other attributes 
can be evaluated in monetary terms. Accordingly, respondents are presented with a set of alternatives 
constructed from different combinations of the levels of attributes, and are asked to choose their most 
preferred. Similarly a choice experiment can be used to examine policy implications of a policy or 
management strategy with policy impacts being the attributes to be valued.  
Before valuing the health damage the establishment of a dose-response function relating pollutant 
concentrations  to  health  impacts  is  required  [12].  The  impacts  of  environmental  degradation  on 
mortality, expressed as the increase in the probability of premature death, and quality of life, expressed 
as reduction of the morbidity risk, are thus initially considered. Accordingly respondents are asked to Int. J. Environ. Res. Public Health 2009, 6                 
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either  state their  willingness  to  pay  for  a  prevention  scenario  (stated  preference  approach)  or the 
benefits are elicited through the costs that would be saved if the risk was eradicated (cost of illness 
studies). Benefits are mainly reported by calculating the Value of a Statistical Life (For a review of the 
literature calculating the value of a statistical life based on labor and housing market data see Viscusi 
and Aldy [13].). The Value of Statistical Life (VSL) is calculated by dividing the value of a small risk 
change  by  the  actual  change  in  risk  and  thus  captures the  effect  of  small  changes  in  the  risk  of 
premature death for a large population of potentially exposed people [14]. 
 Since  primary  data  collection  to  establish  the  dose  response  functions  or  proceed  with  the 
valuations can be expensive and time-demanding, there is substantial policy interest in using benefit 
transfer techniques. In this context, original values from existing studies are transferred to policy sites 
after correcting for certain parameters.Given the number of valuation studies, several meta-analyses 
studies  have  been  recently  conducted.  Following  this  approach  valuation  estimates  from  existing 
studies  are  collected  and  the  determinants  of  these  estimates  are  examined.  In  a  meta-analysis 
regression,  therefore,  the  dependent  variable  is  a  common  summary  statistic,  such  as  a  predicted 
variable for the Willingness to Pay, whereas the independent variables include characteristics of the 
primary data, study design, valuation method, sample size, model specification, econometric methods, 
date of publication [15]. Meta-analyses can feedback the establishment of value transfer functions to 
estimate values for policy sites of interest based on properly adjusted information from existing studies 
on similar sites, study sites [16]. 
Each of the methods described has its own strengths and limitations. The choice between these 
methods  should  be  case-study  driven,  that  is,  it  should  be  a  function  of  case-study-specific  data 
availability and socio-economic-political framework. In human capital surveys it is often difficult to 
assign wages for housework or non-cash labour. Hedonic methods require a well functioning market 
for housing or labour, which internalizes the health risks associated with a location or a job. The cost 
of illness approach fails to capture the full damage of illness, such as psychological suffering and 
physical  pain  and  should  be  thus  treated  as  a  lower  bound  of  the  total  value  of  health  risks  
aversion [17]. Using QALY to estimate the damage costs may also lead to underestimations [18]. 
Opponents  of  QALYs  use  argue  that  these  measures  cannot  in  general  appropriately  represent 
individual preferences for health, while they are consistent with the utility theory under very restrictive 
conditions [19]. QALYs finally ignore the distributional effects arising from the dependence of WTP 
on income. Macroeconomic modelling is often based on simplistic assumption regarding the economy 
while many impacts are unquantifiable and are thus not modelled [5]. 
The contingent valuation method (CVM), although widely used, has been criticised for its lack of 
reliability since it is associated with biases, such as hypothetical bias, strategic bias, yes-saying bias 
and embedding effect [20,21]. Hypothetical bias contends that respondents may be prepared to reveal 
their true values but are not capable of knowing these values without participating in a market in the 
first  place.  Strategic  bias  occurs  when  respondents  deliberately  under-  or  overstate  their  WTP. 
Respondents may understate their WTP if they believe that the actual fees they will pay for provision 
of the environmental resources will be influenced by their response to the CV question. Conversely, 
realising that payments expressed in a CV exercise are purely hypothetical, respondents may overstate 
their true WTP in the hope that this may increase the likelihood of a policy being accepted. Yea-saying 
bias indicates that respondents may express a positive WTP because they feel good about the act of Int. J. Environ. Res. Public Health 2009, 6                 
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giving for a social good although they believe that the good itself is unimportant while embedding bias 
implies that WTP is not affected by the scale of the good being offered. To address these, the Blue 
Ribbon Panel under the auspices of NOAA [22] has made recommendations regarding best practice 
guidelines for the design and implementation of contingent valuation studies.  
Comparing the stated preference methods for environmental valuation Boxall et al. [23] argue that 
choice experiments (CEs) have important advantages over others valuation methods mainly because of 
their experimental nature which enables the representation of different states of the environment using 
attributes and levels of specific choice situations. The latter has a clear benefit compared to other 
valuation methods as it leads respondents to explicitly make trade-offs between the various attributes 
of the situation and thus provides policy-makers with valuable information about public preferences 
for many states of the environment. Environmental health effects of a policy or project can therefore 
be  explicitly  addressed  and  valued.  Both  CVM  and  CEs  studies  represent  preferences  that  are 
consistent with utility theory, with CEs being also able to solve for some of the biases present in the 
CVM. Therefore it is our opinion that the application of CEs should be further enhanced  in health 
economics to evaluate health impacts of environmental policies. 
 
3. Economic Assessment of Environmental Health Impacts: Empirical Evidence 
 
There  is  increasing  recognition  that  linked  environment  and  health  impacts  require  economic 
assessment in order to receive adequate consideration in policy [1]. Consequently, a huge increase in 
the number of  valuation studies trying to quantify the environmental  impacts on human  health  in 
monetary terms and elicit public preferences for health and environmental policies that reduce the risk 
of illness or mortality has been experienced in recent years. 
In  the  subsequent  sections  important  applications  of  the  valuation  techniques  that  have  been 
conducted to estimate social benefits associated with increased air and water quality as well as climate 
change aversion are reviewed. Limitations of the existing research are addressed in the concluding 
section and directions for future work are suggested. For quick reference a table summarizing each 
study’s main features (that is author, case study country, environmental hazard and valuation result) 
can  be  found  in  the  Appendix.  All  valuations  have  been  converted  to  2006  euros  (2006  average  
$0.797 = 1 euro). 
 
3.1. Air Quality 
 
Air pollution is a major environmental risk to health and is estimated to cause approximately two 
million premature deaths worldwide per year [24]. A reduction of air pollution is expected to reduce 
the global burden of disease from respiratory infections, heart disease, and lung cancer. As air quality 
is a major concern for both developed and developing countries, a large number of empirical studies 
attempting to monetize the benefits to health generated by improved air quality have appeared in the 
literature worldwide.  
Pearce [12] provides a summary of the main studies conducted to that day valuing health damages 
from air pollution in the developing world. In particular, valuation estimates for health symptoms and 
risks of mortality attributable to particulate matter, lead, nitrogen and sulphur oxides and low level Int. J. Environ. Res. Public Health 2009, 6                 
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ozone are reported. The main conclusion from the literature review is that some forms of air pollution, 
notably inhalable particulate matter and ambient lead, are serious matters for concern in the developing 
world since they are associated with severe health damages in monetary terms. 
Since then a number of valuation studies have been conducted in developing countries estimating 
social benefits from air pollution reduction in terms of either averted mortality or averted morbidity 
due to air pollution mitigation strategies. To provide economic estimations of health risk reductions 
authors  rely  on  existing  epidemiological  studies  that  establish  the  relationship  between  pollution 
concentrations and health hazards. Valuation studies are then conducted to monetize health outcomes 
given the number of exposures and the associated risk predicted from the dose-response functions.  
In  the  literature  addressing  air  pollution  in  both  developed  and  developing  world,  contingent 
valuation  studies  are  mainly  implemented.  The  health  consequences  from  alternative  pollution 
abatement  policies  are  explicitly  stated  in  the  valuation  scenario  and  respondents  are  asked  their 
maximum willingness to pay to contribute in the implementation costs of the policy under evaluation. 
Mortality and mobility effects of air pollution have been studied through contingent valuation in the 
developing world [25-28]. To provide economic grounds for supporting investment in air pollution 
abatement a cost benefit-analysis is often applied [29-31]. Results from valuation studies adopting a 
benefit transfer framework to circumvent the time and money demands of conducting an original study 
are also reported in the literature [32,33]. A cost of illness approach is employed by Gupta [34] to 
estimate the  monetary  benefits to individuals  from  health damages avoidance due to air pollution 
reduction in India. Health costs are considered to be incurred due to adverse effects of air pollution on 
health i.e., the loss in wages due to workdays lost from work and expenditures on mitigating activities. 
While the majority of studies addressed outdoor air pollution, Chau et al. [35] combine revealed and 
stated preference techniques to estimate the monetary benefit gains from improved indoor air quality. 
Authors  conduct  a  meta-analysis  to  estimate  the  concentration-response  coefficients  for  different 
health  outcomes  to  which  they  then  assigned  economic  value  based  on  existing  values  from  the 
literature. Findings indicate that there would be some benefit gains for the owners-employers and the 
society if certain regular filter sets were adopted. The amount of benefit gains by the owners-employers 
increases with the average salary level of employees and duration that they stay in offices. 
Hedonic  studies  have  been  also  applied  to  estimate  a  relationship  between  housing  prices  and 
housing attributes,  including  health risks  associated with  air pollution. The  value people place on 
reduced health risks through improved air quality are inferred by their willingness to pay more for 
houses with better air quality, all else being equal. Delucchi et al. [36] provide a meta analysis of 
hedonic  pricing  studies  addressing  health  risks  from  air  pollution.  Comparing  results  with  studies 
applying the damage function approach, authors find evidence that hedonic price analysis does not 
capture all of the health costs of air pollution because individuals are not fully informed about all of 
the health effects to incorporate them into property values.  
According  to  the  authors’  knowledge,  in  developed  countries  environmental  health  studies  are 
limited and all consist of contingent valuation studies in Europe. To assess morbidity risk reduction 
benefits, Navrud [37] conduct a contingent valuation study to estimate the willingness-to-pay (WTP) 
to  avoid  additional  days  of  seven  light  health  symptoms  (coughing,  sinus  congestion,  throat 
congestion, eye irritation, and headache, shortness of breath and acute bronchitis) and asthma. Mean 
WTP for an environmental program that would result to reduced health risks (avoiding one additional Int. J. Environ. Res. Public Health 2009, 6                 
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day of the health symptoms) ranges from 16.62 euros for coughing to 44.2 for the shortness of breath. 
Mortality risks reduction, expressed as extension in life expectancy, is addressed by Alberini et al. [38], 
Desaigues et al. [39] and Chilton et al. [40]. Finally,  Aunan et al. [30]  implement a cost-benefit 
analysis to estimate the net benefits of an energy saving program in Hungary that would result to 
significant emissions reductions. The analysis indicates that the main benefit from reduction of the 
concentrations  of  pollutants  relates  to  improved  human  health.  The  estimated  annual  benefit  of 
improved health conditions alone is likely to exceed the investments needed to implement the program 
even under the lowest estimates. A cost-benefit analysis is also applied by Larson et al. [41] to assess 
the efficiency of five projects leading to 25-fold reduction in mortality risk due to particulate emissions 
in  Russia.  The  Value  of  a  Statistical  Life  was  transferred  to  Russia  after  adjustment  to  estimate 
benefits of reduced mortality. The total net present benefit of all five projects is found about $40 
million which justify the undertaking of the projects on economic grounds. 
 
3.2. Water Quality 
 
Contact with unsafe drinking or bathing water can impose serious risks (both acute and delayed) to 
human  health  [42,43].  Microbe  contamination  of  groundwater  due  to  sewage  outfalls  and  high 
concentration of nutrients in marine and coastal waters due to agricultural runoff are among the most 
serious threats [44]. According to the European Commission’s (EC) recent statistics, 20 percent of all 
surface water in the EU is seriously threatened by pollution [45]. In the infrastructurally disadvantaged 
developing world the water contamination problem is even more prominent [46]. 
Although epidemiological studies have provided evidence of severe morbidity attributed to polluted 
water the issue has received limited attention in terms of valuation studies. Only few studies explicitly 
address  health  effects  of  drinking  and  bathing  water  quality  to  inform  efficient  water  resources 
management policies mainly in high income countries. 
The health risks involved in bathing in polluted sea water are explicitly accounted in the study of 
Machato  and  Murato  [47],  who  employed  stated  preference  techniques  to  evaluate  the  multiple 
benefits of improving the quality of marine recreational waters on the Estoril coast in Portugal. Based 
on evidence from existing epidemiological dose-response functions a contingent valuation survey was 
employed to allow  for a direct estimate of the health  benefits of reduced water pollution. Results 
indicate that health risk reductions are only a small fraction of the total social benefits of water quality 
improvements. The sample mean WTP to avoid gastroenteritis was found to be € 55.56. Bathing water 
quality related health benefits are also studied by Johnson et al. [48], who adopted a benefit-transfer 
approach to evaluate health benefits associated with improved bathing water quality in Scotland. A 
dose-response function between the concentration of Intestinal Enterococci in bathing water and the 
probability of contracting gastro-enteritis was first determined and then the annual benefits of illness 
risk reduction were estimated on the WTP values from a stated preference study in England. Health 
benefits from a reduction in the risk of illness resulting from swimming in contaminated waters were 
found to be € 348.000 annually. Georgiou et al. [49] conducted a cost-benefit analysis to inform 
policy-makers in UK on the efficiency of the proposed measures to revise seawater quality standards 
set by the 1976 EC Bathing Water Quality Directive. Benefits were estimated based on data from a 
contingent  valuation  study  and  were  then  related  to  their  costs.  Results  indicate  that  mean  WTP Int. J. Environ. Res. Public Health 2009, 6                 
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amounts, representing the economic benefits of the revision are of the same order of magnitude as the 
estimated potential cost increases  in average annual  household water bills  necessary to implement  
the revision.  
Deviating from the contingent valuation framework, Dwight et al. [43] apply the cost of illness 
approach and Shuval [50] calculate the disability-adjusted life years (DALY), to quantify the health 
burden from illnesses associated with exposure to polluted recreational coastal waters. In the former 
study,  health  data  on  illness-related  lost  activity  days  and  medical  care  use  were  used  and  the 
economic burden per gastrointestinal illness was estimated at € 31.9, the burden per acute respiratory 
disease at € 66.94, the burden per ear ailment at € 32.95, and the burden per eye ailment at € 23.81. In 
the later, the total estimated impact of the human disease attributable to marine pollution by sewage is 
about three  million DALY per  year, with an estimated economic  loss of some11.16  billion euros  
per year. 
In  the  developing  world,  health  damages  from  drinking  water  contamination  are  examined  by 
Dasgupta [46] and Maddison et al. [51] The former study estimates a health production function to 
derive the total cost of illness related to Diarrhoeal diseases in urban India,. Annual health costs are 
calculated  and  aggregated  over  the  whole  population  are  found  to  equal  €  2,821,587.  The  latter 
estimates aggregate willingness to pay to avoid health risks, including various cancers, associated with 
consumption of arsenic contaminated groundwater in Bangladesh. Based on Value of Statistical Life 
estimation from studies in India, authors report an aggregate WTP of $2.7 billion annually to avoid 
mortality and morbidity cases. 
 
3.3. Climate Change  
 
An understanding of the likely impacts of climate change on human welfare is crucial for making 
an  informed  decision  about  the  best  response  strategy  to  the  enhanced  greenhouse  effect. 
Consequently,  a  number  of  studies  have  attempted  the  evaluation  of  climate  change-related  
health hazards.  
Bell  et  al.  [17]  review  the  literature  on  valuation  studies  assessing  health  consequences  from 
greenhouse gases. Results from multiple studies provide strong evidence that the public health benefits 
related to greenhouse gases mitigation strategies are substantial. The review, however, is restricted to 
health benefits from air pollution exposure. Benefits from greenhouse gases mitigation policies are 
also addressed by Burtraw et al. [52]. Authors examine the US electricity sector and value changes to 
human  health resulting  from carbon emissions  based on concentration response  functions.  Results 
indicate health-related ancillary benefits from further reductions in carbon emissions under a € 23.15 
carbon tax to be about € 7.41 per metric ton of carbon reduced in the year 2010.  
A  review  of  the  literature  evaluating  the  welfare  impacts  of  climate  change,  including  climate 
variation-related diseases is also presented in Tol [5]. However the studies included provide a total cost 
estimation of the climate change in $ per tonne of carbon and health effects are not distinguished. 
Based  on  the  existing  literature,  Tol  concludes  that  policy  response  to  climate  change  should  be 
dominated by adaptation, not by mitigation.  Int. J. Environ. Res. Public Health 2009, 6                 
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Welfare losses associated with health impacts induced by global warming are also estimated by 
Bosello et al. [9]. Authors apply a general equilibrium macroeconomic model to infer costs estimates 
relating  to  cardiovascular  and  respiratory  disorders,  diarrhoea,  malaria,  dengue  fever  and 
schistosomiasis  occurrences  through  changes  in  labour  productivity  and  demand  for  health  care. 
Consistent with the literature, results imply the welfare costs (or benefits) of health impacts contribute 
substantially to the total costs of climate change both in terms of GDP and investment. 
Bateman et al. [53] apply a contingent valuation study to assess WTP for reductions in the skin 
cancer risks associated with exposure to solar UV radiation. A common valuation scenario was applied 
to four countries (New Zealand, Scotland, England, and Portugal) across which objectively measured 
risk  levels,  for  example  cancer  rates,  vary  substantially.  Authors  intended  to  examine  whether 
scientifically established health risks are reflected in WTP for risk reductions in these countries and 
results confirm that differences in stated WTP between countries reflects the variation in risk levels 
between those countries. 
Health effects from illnesses associated with climate change are also examined in the developing 
world by Tseng et al. [54] using the dengue fever in Taiwan as a case study. The relationship between 
climate conditions and the number of people infected by dengue fever was first established and the 
monetary assessment was then attempted applying a contingent valuation study. Results indicate that 
people would pay € 15.78, € 70.35 and € 111.62 per year in order to reduce the probabilities of dengue 
fever inflection by 12%, 43%, and 87%, respectively. 
 
4. The Use of Valuation Results in Policy Design 
 
Climate change and anthropogenic forcing threaten environmental stability and with it ecosystems’ 
capacity  to  provide  goods  and  services  that  can  be  translated  to  economic  benefits  for  humans 
including values associated with health quality and death mitigation. Although environmental goods 
and services have value to society, are often neglected in policy-making as they are not traded in 
markets and as such are not priced. A primary cause for environmental degradation and consequent 
health  hazards  is  failure  to  identify  and  internalize  in  decision-making  the  economic  value  of 
ecosystems. Given the public nature of the environmental resources, market data, if available at all, 
can lead to misleading decisions regarding the significance of resources protection resulting in further 
resources depletion and degradation. Therefore economic valuation is extremely crucial to provide the 
correct economic indicators and signals for the design of efficient and sustainable economic policies. 
In  the  absence  of  markets,  valuation  studies  can  provide  policy-makers  with  the  necessary 
information to acknowledge the contribution of health benefits in the social welfare associated with 
environmental resources justifying the need for policy intervention to eliminate health effects from 
environmental  hazards.  Further,  preference  elicitation  for  different  socio-economic  groups  and 
knowledge of the  marginal  valuation each group attaches to environmental  improvements through 
valuation  studies  allows  for  equity  considerations  to  be  taken  into  account  in  the  formulation  of  
policy responses. 
Once aggregated over the full range of beneficiaries, monetary benefits estimated through valuation 
studies can be compared with the costs of the relevant environmental or health intervention policies 
through cost-benefit analysis to derive useful  information on the efficiency of the planned policy. Int. J. Environ. Res. Public Health 2009, 6                 
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Welfare changes  from alternative policy  initiatives can  be also assessed and the  impact of social, 
economic  and  attitudinal  characteristics  on  individual  valuation  can  be  examined.  In  this  respect, 
valuation studies are significant for policy-making to guide the selection of economic instruments to 
allocate resources among socially valuable endeavours [55].  
Economic instruments should provide the necessary incentives to all different stakeholders to act in 
a  sustainable  way.  To  halt  environmental  degradation  and  associated  health  effects  economic 
instruments should  intend to provide  incentives  for adopting preventative  measures and refraining 
from polluting activities. Instruments for natural resources management include standards and quotas, 
abstraction and pollution taxes, subsidies and tradable permits. Taxes, subsidies and quotas are fiscal 
policy instruments that can internalize the external costs created by natural resources use and if set at 
the  social  optimal  level  can  ensure  full  cost  pricing  of  the  environmental  goods  and  services,  a 
necessary condition for sustainability. Tradable permits systems have been implemented in a number 
of countries for several pollutants and are also intoduced by the Kyoto protocol with the intention of 
reducing the greenhouse gases emissions in the contracting counties. Under tradable emission permits, 
a market for environmental quality is created in which the right to use the environment as a waste sink 
is priced, and traded [56]. Further liability systems (legal liability, non-compliance charges) intending 
to  internalize  and  recover  the  costs  of  environmental  damage  through  legal  action  causes  can  be 
established. All instruments should be consistent with the ‘polluter pays principle’ which ensures that 
the cost of environmental pollution is charged to users and should intend full cost recovery of the 
environmental damage. Distributional, environmental and sustainability effects of the implementation 
of each instrument should also be considered and valuation studies can be really informative in this 
respect. This is particularly valid for the the developing countries where decision makers are faced 
with the challenge of mitigating environmental risks while supporting economic growth. To ensure 
environmental protection while enhancing economic development, economic instruments should be 
properly designed and implemented and in this respect information from valuation studies is crucial.  
Information from valuation studies can also assist the design of efficient insurance programs to 
mitigate health effects resulting from environmental stresses. Knowledge of social perception of the 
effects of health risks is crucial for the formulation of optimal risk mitigation/hedging strategies. These 
strategies should be able to allocate the aggregate social health risk between socio-economic groups in 
order to provide efficient, equitable and sustainable coverage against environmental health hazards. 
 
5. Concluding Remarks 
 
Environmental  degradation  poses  a  significant  threat  to  human  health  worldwide.  Harmful 
consequences of this degradation to human health are already being felt and could grow significantly 
worse over the next 50 years [2]. Because environment and health are so intimately linked, so too 
should be environmental and health policies. However, health impacts are non-marketed and thus hard 
to quantify  in  monetary terms. The  subsequent risk of  being  ignored in policy-making  is a  major 
concern worldwide. To address this challenge a number of valuation studies have been conducted in 
both developing and developed countries applying different methods to capture health benefits from 
improved  environmental  quality.  Valuation  results  are  crucial  for  the  formulation  of  economic 
instruments to internalize the externalities created by the public nature of environmental resources. The Int. J. Environ. Res. Public Health 2009, 6                 
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application of fiscal instruments, the introduction of charge systems and/or the creation of emission 
markets can only promote sustainable outcomes if set at a social optimal level. Elicitations of the 
preferences and valuations of different social groups through valuations is therefore essential. This 
paper reviews the main literature in the field. Although not exhaustive, applied research cited in this 
review provides substantial evidence of strong correlation between exposure to environmental hazards 
and  health risks and reveals that there are significant values associated with  longevity and  health 
quality in both developed and developing world justifying the need for policy interventions.  
Enhancing air quality and  securing adequate supplies of  safe drinking water  is  associated with 
significant  benefits  for  human  health  and  well-being.  Significant  benefits  are  also  found  to  be 
associated  with  bathing  water  quality  socially  justifying  the  costs  for  abatement  policies.  Climate 
change effects mitigation is also of great importance in terms of public health benefits. However, 
certain limitations of the existing literature have been identified. 
Pearce [12] argued that a major weakness of the air pollution damage literature has been the focus 
on outdoor pollution. Still, remarkably few studies have measured indoor air pollution which could be 
the focus of future research. It is also noteworthy that only contingent valuation studies have been 
conducted when stated preference techniques are applied to elicit public preferences for improved air 
quality.  However  the  Contingent  Valuation  method  is  found  to  be  associated  with  several  biases 
(strategic bias, yes-saying bias and embedding effect among others) and thus the Choice Experiment 
method could provide more reliable results [57]. Future valuation efforts could therefore apply this 
relatively new stated preference method to assess the social benefit associated with policies attempting 
to improve air quality. Finally there are considerably few valuation studies on environmental health 
risks of air pollution in Europe. 
Regarding health hazards relating to water, although an international  consensus has emerged in 
policy regarding water quality based on growing concern on environmental and health issues there are 
few valuation studies eliciting public preferences for improved water quality and subsequently reduced 
illness risk. The need for economic analysis is, however, highly acknowledged as explicitly manifested 
in  the  recently  adopted  EU  Water  Framework  Directive  (2000/60/EC)  [58]  which  calls  for  the 
application of economic principles, economic methods and economic instruments for achieving good 
water status for all EU waters in the most effective manner [59,60]. Given European and international 
calls for sustainable water resources management, authors believe that valuing health benefits from 
surface  and  groundwater  water  quality  improvements  could  be  a  challenging  direction  for  future 
research especially in the developing world where water quality issues are particularly prominent and 
the lack of valuations studies is noteworthy.  
Moreover, to  provide  accurate  monetary  estimates  of  the  benefits  of  reduced  health  symptoms 
associated with environmental hazards, collaboration between economists and epidemiologists should 
be further enhanced to establish more informed dose-response functions and accordingly formulate the 
valuation scenarios. Finally, since health benefits from environmental improvements accrue in the long 
run  their  assessment  should  recognize  their  long-run  nature.  It  follows  that  discounting  and  the 
subsequent selection of a social discount rate to discount future benefits from a policy intervention is 
crucial  to  determine  whether  a  policy  passes  a  cost-benefit  analysis  test taking  sustainability  and  
inter-generational equity into consideration [61]. 
 Int. J. Environ. Res. Public Health 2009, 6                 
      
 
2172 
Appendix 
 
Summary of Valuation Studies 
Author  Study 
Area 
Valuation 
Technique 
Environmental 
hazard 
Results 
Brajer et al. 
2006 [32] 
Hong-
Kong  
Dose –response 
function/ benefits 
transfer 
Air pollution  Authors find that there remain significant 
health gains, ranging between €1.4 billion 
and € 4.6 billion over the period 2003–
2012 that could be achieved should Hong 
Kong further reduce ambient pollution 
levels. 
 
Mead and 
Brajer 2006 
[33] 
China   Dose –response 
function/ benefits 
transfer 
Air pollution  Authors report a total valuation of over € 
9.9 billion for a program that would result 
in  nearly  a  billion  morbidity  instances 
avoidance. 
 
Li et al. 2003 
[29] 
Shanghai  Benefit-Cost ratio  Air pollution  The  study  shows  that  the  benefit-to-cost 
ratio  is  in  the  range  of  1  to  5  for  the 
power-sector initiative and 2 to 15 for the 
industrial-sector  initiative.  Thus,  there 
appear  to  be  substantial  benefits 
associated  with  air  pollution  control  in 
developing cities. 
 
Aunan et al. 
1998 [30] 
Hungary  Cost-Benefit 
Analysis  
Air pollution  The estimated annual benefit of improved 
health conditions alone is likely to exceed 
the investments needed to implement the 
program even under the lowest estimates. 
 
Miraglia 
2007 [31] 
Brasil  Cost-Benefit 
Analysis  
Air pollution  Estimated benefits using an averted 
behaviour technique far outweighed 
measured costs indicating that Sao Paulo 
would benefit from the biodiesel use. 
Wang and 
Mullahy 
2006 [25] 
China   Contingent 
Valuation 
Air pollution  Authors report that respondents are on 
average willing to pay WTP of € 28.7 for 
a program that would cut one quarter of 
premature deaths due to air pollution. 
Wang and 
Zhang 2009 
[26]  
China  Contingent 
Valuation 
Air pollution  The mean WTP was estimated to be 
€10.79 per person per year 
Chau et al. 
2007 [35] 
  Revealed and Stated 
Preference 
techniques /Meta-
analysis  
Air pollution  Findings indicate that there would be 
some benefit gains for the owners-
employers and the society if certain 
regular filter sets were adopted. 
Gupta 2008 
[34] 
India  Cost of illness  Air pollution  Results  indicate  that  the  mean  worker 
from Kanpur would gain € 2.61 per year if 
air pollution were reduced to a safe level.  
 
Hammit and 
Zhou 2006 
[27] 
China  Contingent 
Valuation 
Air pollution  The sample average median WTP to 
prevent an episode of cold ranges between 
€ 2.5 and € 4.99 while the WTP to prevent 
a statistical case of chronic bronchitis 
ranges between € 416 and € 832.73. 
Alberini et 
al. 1997 [28] 
Taiwan  Contingent 
Valuation 
Air pollution  Median WTP to avoid a recurrence of the 
average episode is found to be € 41.35. 
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Summary of Valuation Studies. Cont. 
 
Navrud 2001 
[37] 
Norway  Contingent 
Valuation 
Air pollution  Mean WTP for an environmental program 
that would result to reduced health risks 
(avoiding one additional day of the health 
symptoms)  ranges  from  €16.62  for 
coughing  to  €44.2  for  the  shortness  of 
breath.  
 
Alberini et 
al. 2006 [38] 
UK, France 
and Italy 
Contingent 
Valuation 
Air pollution  Mean  WTP  from  the  pooled  sample  is 
€1168 per year for a 5 to 1000 mortality 
risk reduction while the value of a loss of 
one  year’s  life  expectancy  is  between 
€56,903 and €146,913. 
 
Desaigues et 
al. 2003 [39] 
France  Contingent 
Valuation 
Air pollution  Mean WTP for a mortality risk reduction 
of 1 to 1000 between the age of 70 and 80 
is € 458.6. 
Chilton et al. 
2004 [40] 
UK  Contingent 
Valuation 
Air pollution  Mean annual WTP is € 138.82 for the one 
month life expectancy extension sample, € 
157.31 for the three months sample, and € 
187.38 for the six months sample. 
Larson et al. 
1999 [41] 
Russia  Value of a 
Statistical Life/ 
Cost-Benefit 
Analysis 
Air pollution   The  total  net  present  benefit  of  five 
projects to reduce particulate emissions is 
estimated at about € 37.23 million 
Machato and 
Murato 2002 
[47] 
Portugal   Contingent 
Valuation/ 
Contingent ranking 
Bathing water 
pollution 
The  sample  mean  WTP  to  avoid 
gastroenteritis episodes was found to be € 
55.56. 
 
Johnson et 
al. 2008 [48] 
Scotland  Dose response 
function/Benefit 
Transfer 
Bathing water 
pollution 
Health  benefits  from  a  reduction  in  the 
risk of illness resulting from swimming in 
contaminated waters were found to be € 
348.000 annually. 
 
Georgiou et 
al. 2000 [49] 
UK  Cost-Benefit 
Analysis 
Bathing water 
pollution 
Results indicate that mean WTP amounts, 
representing the economic benefits of the 
revision are of the same order of 
magnitude as the estimated potential cost 
increases in average annual household 
water bills necessary to implement the 
revision. 
Dasgupta 
2004 [46] 
India  Cost of illness  Drinking water 
pollution 
Annual health costs related to Diarrhoeal 
diseases  are  aggregated  to  the  whole 
population are found to equal € 34.19. 
 
Dwight et al. 
2005 [43] 
US  Cost of illness  Bathing water 
pollution 
The economic burden per gastrointestinal 
illness was estimated at € 31.9, the burden 
per  acute respiratory  disease  at  €  66.94, 
the burden per ear ailment at € 32.95, and 
the burden per eye ailment at € 23.81.  
 
Shuval 2003 
[50] 
World  Disability-Adjusted 
Life Years (DALY) 
Bathing water 
pollution 
The total estimated impact of the human 
disease attributable to marine pollution by 
sewage is about 3 million DALY per year, 
with an estimated economic loss of some 
€ 11.16 billion per year. 
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Summary of Valuation Studies. Cont. 
 
Maddison et 
al. 2005 [51] 
Bangladesh   Value of Statistical 
Life 
Groundwater 
contamination with 
Arsenic 
Authors  report  an  aggregate  WTP  of  € 
2.26  billion  annually  to  avoid  mortality 
and morbidity cases 
Burtraw et 
al. 2003 [52] 
US  Carbon tax  Climate Change   Authors  find  health-related  ancillary 
benefits from further reductions in carbon 
emissions under a € 23.15 carbon tax to be 
about  €  7.41  per  metric  ton  of  carbon 
reduced in the year 2010. 
 
Bosello et al. 
2006 [9] 
World  General equilibrium 
macroeconomic 
model 
Climate Change  Results  imply  the  welfare  costs  (or 
benefits)  of  health  impacts  contribute 
substantially to the total costs of climate 
change  both  in  terms  of  GDP  and 
investment 
Bateman et 
al.2005 [53] 
Portugal, 
England, 
Scotland, 
New 
Zeland 
Contingent 
Valuation/ Natural 
Experiment 
Climate Change  For  both  the  private  and  public 
good,proposed to reduce health risks from 
exposure  to  solar  radiation,  WTP  is 
highest  in  New  Zealand  followed  by 
Scotland  and  England,  with  the  lowest 
value  being  given  by  the  Portuguese 
sample. Results suggest that WTP reflects 
differences  in  exogenous  health  risks  in 
the four countries. 
 
Tseng et al. 
2009 [54] 
Taiwan  Contingent 
Valuation  
Climate Change   Results indicate that people would pay € 
15.78, €  70.35 and € 111.62 per year in 
order to reduce the probabilities of dengue 
fever inflection by 12%, 43%, and 87%, 
respectively. 
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